Views & Analysis | Perspectives on pharma industry issues

Market Access

Two pills in the middle of multiple £1 coins

UK’s next pricing and access scheme to last for 7 years

Operational review meeting minutes released by the DHSC reveal industry and government are planning to move to a 7-year agreement.

Market Access

Magnifying glass over pills scattered over dollar and euro notes

One year after MFN: How US policy is reshaping the global ph...

Just over a year has passed since the Trump administration sent letters to 17 leading manufacturers demanding steps towards MFN pricing.

Digital

Medtech's digital experience is ready for an upgrade

Medtech companies need to hold their software experience design to the same standard as the best digital products people use every day.

Patients

Breaking Bipolar I disorder stigma in the Hispanic community

For many Hispanic patients and families, that is where the gap between need and treatment can begin.

Digital

AI-native clinical research concept of HCP, clipboard, and AI capabilities overlain

Building an AI-native CRO

Artificial intelligence is transforming nearly every industry. In clinical research, the question isn't whether to use AI, but how to use it meaningfully.

Views & Analysis

Sharing success to unlock the “triple win” of joint working

The fortunes of the NHS and the UK’s life sciences industry are intertwined, with each sector’s success or failure heavily dependent on the other.

Views & Analysis

Bringing innovative trials to the UK

We spoke with the National Institute for Health Research’s (NIHR) senior business development manager, Anjna Rising, to learn how the NIHR is approaching innovative clinical trials and fosterin

Views & Analysis

Addressing the medical cannabis knowledge gap

The legalisation of medical cannabis in November 2018 was hailed as a landmark victory for the British medical industry, with scientists, researchers and patients alike all welcoming the ch

Sales & Marketing

Why Klick Health, Oxford PharmaGenesis chose to join forces

Leadership from Klick Health and Oxford PharmaGenesis discuss their

Sales & Marketing

Are Insights leaders seeing real commercial value from AI ad...

Day One Strategy’s second annual AI in Pharma State of Play report addresses the challenges Pharma Insights teams are facing as AI adoption continues.

Digital

Medtech's digital experience is ready for an upgrade

Medtech companies need to hold their software experience design to the same standard as the best digital products people use every day.

Digital

Building an AI-native CRO

Artificial intelligence is transforming nearly every industry. In clinical research, the question isn't whether to use AI, but how to use it meaningfully.